Dunja Dogan
Papers
1
Total Citations
5
H-Index
1
About
Dunja Dogan is a pharmaceutical scientist whose research focuses on the critical intersection of biopharmaceutical formulation, stability, and advanced compounding technologies. Her work addresses a pivotal challenge in modern medicine: ensuring the safety and efficacy of monoclonal antibodies during clinical preparation. In her most-cited study, "Aggregate Formation and Antibody Stability in Infusion Bags: The Impact of Manual and Robotic Compounding of Monoclonal Antibodies" (2023), Dogan provides groundbreaking insights into how different compounding methods—manual versus robotic—affect protein aggregation and antibody stability. This research is vital for hospitals and pharmacies transitioning to automated systems, as it directly impacts patient safety by identifying factors that can compromise drug quality. With 5 citations in a short time, her work is gaining traction among formulation scientists and clinical pharmacists. Dogan’s contributions are particularly notable for bridging the gap between laboratory science and real-world clinical practice, offering actionable data to optimize compounding protocols. Her research not only advances the understanding of protein behavior in infusion bags but also supports the broader adoption of robotic compounding to enhance precision and reduce human error.
Research Focus
Key Achievements
Top Papers
- 1